Rajamohan F, Ozer Z, Mao C, Uckun F M
Biotherapy Program, Parker Hughes Cancer Center, Parker Hughes Institute, St. Paul, Minnesota 55113, USA.
Biochemistry. 2001 Aug 7;40(31):9104-14. doi: 10.1021/bi002851p.
Pokeweed antiviral protein (PAP) is a ribosome-inactivating protein (RIP) which catalytically cleaves a specific adenine base from the highly conserved alpha-sarcin/ricin loop (SRL) of the large ribosomal RNA and thereby inhibits the protein synthesis. The ribosomal protein L3, a highly conserved protein located at the peptidyltransferase center of the ribosomes, is involved in binding of PAP to ribosomes and subsequent depurination of the SRL. We have recently discovered that recombinant PAP mutants with alanine substitution of the active center cleft residues (69)NN(70) (FLP-4) and (90)FND(92) (FLP-7) that are not directly involved in the catalytic depurination at the active site exhibit >150-fold reduced ribosome inhibitory activity [(2000) J. Biol. Chem. 275, 3382--3390]. We hypothesized that the partially exposed half of the active site cleft could be the potential docking site for the L3 molecule. Our modeling studies presented herein indicated that PAP residues 90--96, 69--70, and 118--120 potentially interact with L3. Therefore, mutations of these residues were predicted to result in destabilization of interactions with rRNA and lead to a lower binding affinity with L3. In the present structure-function relationship study, coimmunoprecipitation assays with an in vitro synthesized yeast ribosomal protein L3 suggested that these mutant PAP proteins poorly interact with L3. The binding affinities of the mutant PAP proteins for ribosomes and recombinant L3 protein were calculated from rate constants and analysis of binding using surface plasmon resonance biosensor technology. Here, we show that, compared to wild-type PAP, FLP-4/(69)AA(70) and FLP-7/(90)AAA(92) exhibit significantly impaired affinity for ribosomes and L3 protein, which may account for their inability to efficiently inactivate ribosomes. By comparison, recombinant PAP mutants with alanine substitutions of residues (28)KD(29) and (111)SR(112) that are distant from the active center cleft showed normal binding affinity to ribosomes and L3 protein. The single amino acid mutants of PAP with alanine substitution of the active center cleft residues N69 (FLP-20), F90 (FLP-21), N91 (FLP-22), or D92 (FLP-23) also showed reduced ribosome binding as well as reduced L3 binding, further confirming the importance of the active center cleft for the PAP--ribosome and PAP--L3 interactions. The experimental findings presented in this report provide unprecedented evidence that the active center cleft of PAP is important for its in vitro binding to ribosomes via the L3 protein.
商陆抗病毒蛋白(PAP)是一种核糖体失活蛋白(RIP),它能催化性地从大核糖体RNA高度保守的α-肌动蛋白/蓖麻毒素环(SRL)中切割出一个特定的腺嘌呤碱基,从而抑制蛋白质合成。核糖体蛋白L3是一种高度保守的蛋白,位于核糖体的肽基转移酶中心,参与PAP与核糖体的结合以及随后SRL的脱嘌呤作用。我们最近发现,活性中心裂隙残基(69)NN(70)(FLP-4)和(90)FND(92)(FLP-7)被丙氨酸取代的重组PAP突变体,这些残基不直接参与活性位点的催化脱嘌呤作用,其核糖体抑制活性降低了150倍以上[(2000)《生物化学杂志》275,3382 - 3390]。我们推测,活性位点裂隙部分暴露的一半可能是L3分子的潜在对接位点。本文所呈现的建模研究表明,PAP的90 - 96、69 - 70和118 - 120位残基可能与L3相互作用。因此,预计这些残基的突变会导致与rRNA相互作用的不稳定,并导致与L3的结合亲和力降低。在目前的结构 - 功能关系研究中,用体外合成的酵母核糖体蛋白L3进行的共免疫沉淀试验表明,这些突变的PAP蛋白与L3的相互作用较弱。通过速率常数和使用表面等离子体共振生物传感器技术的结合分析,计算了突变PAP蛋白与核糖体和重组L3蛋白的结合亲和力。在这里,我们表明,与野生型PAP相比,FLP - 4/(69)AA(70)和FLP - 7/(90)AAA(92)对核糖体和L3蛋白的亲和力显著受损,这可能解释了它们无法有效使核糖体失活的原因。相比之下,远离活性中心裂隙的残基(28)KD(29)和(111)SR(112)被丙氨酸取代的重组PAP突变体对核糖体和L3蛋白显示出正常的结合亲和力。活性中心裂隙残基N69(FLP - 20)、F90(FLP - 21)、N91(FLP - 22)或D92(FLP - 23)被丙氨酸取代的PAP单氨基酸突变体也显示出核糖体结合减少以及L3结合减少,进一步证实了活性中心裂隙对PAP - 核糖体和PAP - L3相互作用的重要性。本报告中呈现的实验结果提供了前所未有的证据,表明PAP的活性中心裂隙对于其通过L3蛋白在体外与核糖体的结合很重要。